Management of VTE:
From Evidence to Practice
Tuesday, 5 November 2024
Middle East, Russia and Africa
(MERA) Session
Dr Alexander T. Cohen
Vascular Physician and Epidemiologist
Department of Haematological Medicine
Guys and St Thomas’ Hospitals NHS Foundation Trust, King’s College London
Country/region
Morocco, Nigeria
16:30 – 17:15
South Africa, Egypt, Lebanon
17:30 – 18:15
Bahrain, Iraq, Jordan, Kuwait,
Qatar, Russia*, Saudi Arabia, Turkey
18:30 – 19:15
Oman, United Arab Emirates
19:30 – 20:15
*time zone based on Moscow, Standard Time (UTC +3)
Tuesday, 5 November 2024
Asia Session
Dr Alexander T. Cohen
Vascular Physician and Epidemiologist
Department of Haematological Medicine
Guys and St Thomas’ Hospitals NHS Foundation Trust, King’s College London
Country/region
Pakistan
16:30 – 17:15
India
17:00 – 17:45
Indonesia*, Thailand, Vietnam
18:30 – 19:15
Hong Kong, Malaysia, Philippines,
Singapore, Taiwan
19:30 – 20:15
*time zone based on Western Indonesia (UTC +7)
Wednesday, 6 November 2024
Latin America (LATAM)
Session
Dr Alexander T. Cohen
Vascular Physician and Epidemiologist
Department of Haematological Medicine
Guys and St Thomas’ Hospitals NHS Foundation Trust, King’s College London
Country/region
Costa Rica, Guatemala, Mexico*
16:30 – 17:15
Colombia, Ecuador**, Panama, Peru
17:30 – 18:15
Bolivia, Dominican Republic
18:30 – 19:15
Argentina, Brazil †, Chile ‡, Paraguay, Uruguay
19:30 – 20:15
*time zone based on Mexico City, Central Standard Time (UTC -6)
**time zone based on Quito, Ecuador Time (UTC -5)
†time zone based on São Paulo, Brasilia Time (UTC -3)
‡time zone based on Santiago, Chile Summer Time (UTC -3)
OBJECTIVES
Discuss the role of DOACs in the management of
patients with VTE, including considerations for
patients with Cancer Associated Thrombosis (CAT).
Review the current evidence and guidelines recommendations
on the treatment of VTE/CAT.
Define the current approaches / challenges in the
management of VTE/CAT in real-world practice,
including practical considerations for long-term/
extended treatment.
AGENDA
Management of Patients with VTE, Including Those with Cancer
Implications for Long-Term Treatment of VTE in
Patients, Including Those with Cancer
Treating Patients with VTE and Cancer